An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Survivorship Care for Patients Living with Metastatic Breast Cancer 1.00 03/15/2025 - 12:00am to 03/15/2026 - 12:00am
Biomarker Testing and Interpretation after Breast Cancer Diagnosis 0.75 03/15/2025 - 12:00am to 03/15/2026 - 12:00am
NCCN Guidelines® Insights - Testicular Cancer, Version 2.2025 1.00 04/10/2025 - 12:00am to 04/10/2026 - 12:00am
Refining Therapeutic Approaches in Relapsed/Refractory Multiple Myeloma: Expert Guidance on Bispecific Antibody Therapy Optimization 1.00 04/11/2025 - 12:00am to 04/11/2026 - 12:00am
Optimizing Patient Outcomes - Understanding the Mismatch Repair Deficient (dMMR)/Microsatellite-High (MSI-H) Treatment Options in Upper... 1.00 04/24/2025 - 12:00am to 10/05/2025 - 12:00am
Optimizing Patient Outcomes - New Primary Therapy Options for Stage III-IV Hodgkin Lymphoma 1.00 04/24/2025 - 12:00am to 11/16/2025 - 12:00am
Unraveling Cancer Pain Dynamics (Recorded Presentations) 05/01/2025 - 3:00pm to 10/31/2025 - 11:59pm
Session 2: Therapeutic Approaches to Cancer Pain 1.00 05/01/2025 - 3:00pm to 10/31/2025 - 11:59pm
Session 3: Individualized Opioid Management in Oncology 1.00 05/01/2025 - 3:00pm to 10/31/2025 - 11:59pm
Session 4: Interdisciplinary Collaboration in Cancer Pain Management 1.00 05/01/2025 - 3:00pm to 10/31/2025 - 11:59pm
Session 1: Fundamentals of Cancer Pain Management 1.00 05/01/2025 - 3:00pm to 10/31/2025 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates 1.00 05/02/2025 - 12:00am to 05/02/2026 - 12:00am
Archived NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease 1.00 05/06/2025 - 12:00am to 04/30/2026 - 12:00am
NCCN Guidelines® Insights - Multiple Myeloma, Version 1.2025 1.00 05/10/2025 - 12:00am to 05/10/2026 - 12:00am
Recorded Presentation from Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma 1.00 05/27/2025 - 12:00am to 05/27/2026 - 12:00am

Pages